Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Inhibikase Therapeutics (IKT) Shares Outstanding (2023)

Historic Shares Outstanding for Inhibikase Therapeutics (IKT) over the last 1 years, with Q4 2023 value amounting to $12000.0.

  • Inhibikase Therapeutics' Shares Outstanding changed N/A to $12000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $12000.0, marking a year-over-year change of. This contributed to the annual value of $12000.0 for FY2023, which is N/A changed from last year.
  • As of Q4 2023, Inhibikase Therapeutics' Shares Outstanding stood at $12000.0.
  • Inhibikase Therapeutics' Shares Outstanding's 5-year high stood at $12000.0 during Q3 2023, with a 5-year trough of $12000.0 in Q3 2023.